Huang D B, Chang C H, Ainsworth C, Johnson G, Solomon A, Stevens F J, Schiffer M
Center for Mechanistic Biology and Biotechnology, Argonne National Laboratory, IL 60439, USA.
Mol Immunol. 1997 Dec;34(18):1291-301. doi: 10.1016/s0161-5890(98)00002-9.
Antibody light chains of the kappa subgroup are the predominant light chain component in human immune responses and are used almost exclusively in the antibody repertoire of mice. Human kappa light chains comprise four subgroups. To date, all crystallographic studies of human kappa light chains were carried out on proteins of the kappaI subgroup. The light chain produced by multiple myeloma patient Len. was of the kappaIV subgroup, it differed by only one residue from the germ-line gene encoded protein. The variable domain fragment of the light chain was crystallized from ammonium sulfate in space group C222(1). The crystal structure was determined by molecular replacement and refined at 1.95 A resolution to an R-factor of 0.15. Protein Len has six additional residues in its CDR1 segment compared to the kappaI proteins previously characterized. The kappaIV variable domain, Len, differs in only 23 of 113 residues from murine kappa light chain McPC603. The RMS deviation upon superimposing their alpha-carbons was 0.69 A. The CDR1 segment of the human and murine variable domains have the same length and conformation although their amino acid sequences differ in 5 out of 17 residues. Structural features were identified that could account for the significantly higher stability of the human kappaIV protein relative to its murine counterpart. This human kappaIV light chain structure is the closest human homolog to a murine light chain and can be expected to facilitate detailed structural comparisons necessary for effective humanization of murine antibodies.
κ亚组的抗体轻链是人类免疫反应中的主要轻链成分,并且几乎专门用于小鼠的抗体库。人类κ轻链包括四个亚组。迄今为止,所有关于人类κ轻链的晶体学研究都是针对κI亚组的蛋白质进行的。多发性骨髓瘤患者Len产生的轻链属于κIV亚组,它与种系基因编码的蛋白质仅相差一个残基。轻链的可变结构域片段从硫酸铵中结晶,空间群为C222(1)。晶体结构通过分子置换确定,并在1.95 Å分辨率下精修至R因子为0.15。与先前表征的κI蛋白质相比,蛋白质Len在其CDR1区段有六个额外的残基。κIV可变结构域Len与小鼠κ轻链McPC603在113个残基中只有23个不同。它们的α-碳原子叠加时的均方根偏差为0.69 Å。尽管人类和小鼠可变结构域的CDR1区段氨基酸序列在17个残基中有5个不同,但它们的长度和构象相同。已鉴定出一些结构特征,这些特征可以解释人类κIV蛋白质相对于其小鼠对应物具有显著更高的稳定性。这种人类κIV轻链结构是与小鼠轻链最接近的人类同源物,有望促进对小鼠抗体进行有效人源化所需的详细结构比较。